INMB INmune Bio Inc.

XNAS 0.89 +0.00% After hours
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

INMB $0.89 ▲ +0.00%
Key stats
$0.89
After hours $0.89 +0.00%
52-Week Range
$0.89 – $2.60
YTD
-41.94%
IV Rank (30D)
49.62
Straddle Price
$0.55
P/C Vol Ratio
0.44
Market Cap
$0.0B
Open
$1.03
Day Range
$0.89 – $1.03
Volume
411,620
Prev Close
$1.03
Fair Value
+50.0% vs price

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)5.12%
Beta vs SPY1.22
Cost of Equity (CAPM)11.82% (VRP-adj)
WACC11.75%
Volatility Risk Premium+330.8pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)-93.8%
Book / Price63.1% — banking bias active (P/B is primary)
Debt / Equity0.00
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$1.67 (Market Anchor value)
SMA 20 / Bollinger Mid$1.26
Bollinger Width / SMA2066.7% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Peers used for multiples: AMGN, BIIB, EXEL, GILD, HALO, KYMR, MRNA, NBIX, RVMD, TECH (SIC-code peers; ETF co-membership was sector-incoherent)
Blended Fair Value
$5.92
Deviation
+50.0%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 25.1× · 6 peers
Peer EV/EBITDA n/a 0% median 16.9× · 7 peers
Peer P/B $5.92 100% median 9.1× · 9 peers
Peer P/S n/a 0% median 6.8× · 10 peers
Market Anchor (SMA50) $1.67 0% stability 0% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-11-19 · updated
About
Industry (SIC)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) (2836) · industry map
Exchange
XNAS
Market Cap
$0.0B
Employees
21
List Date
2019-02-04
CIK
0001711754
Last Earnings
Oct 30 after close · +5.8% vs ±63.6% expected
Headquarters
Boca Raton, FL
Homepage
https://www.inmunebio.com

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart

Markers: Click a marker type to show or hide it. Earnings turn amber when the stock moved more than options implied; hollow markers are still to come, or insider trades under a 10b5-1 plan. Intraday times are New York time; shaded bars are pre-market and after-hours.

Seasonality
Month'21'22'23'24'25'26Avg
Jan3.34%-5.61%27.87%6.33%106.09%3.25%23.55%
Feb-12.37%-15.55%9.01%10.16%-17.73%-18.35%-7.47%
Mar-29.99%1.08%-30.76%-5.17%0.90%-15.04%-13.16%
Apr-3.65%-10.16%4.92%2.78%3.56%16.26%2.29%
May13.47%-12.66%7.21%-18.53%-2.77%-6.62%-3.32%
Jun28.39%34.14%15.82%-8.41%-67.87%17.27%3.22%
Jul-17.28%2.28%-7.65%2.02%30.62%4.48%2.41%
Aug45.61%-10.63%-5.04%-16.31%-20.70%24.32%2.88%
Sep-18.64%-23.74%-18.97%-12.36%5.08%-12.95%-13.60%
Oct-9.76%25.12%10.45%6.17%-14.08%-24.87%-1.16%
Nov-33.63%-7.86%33.66%-16.39%-3.33%-34.06%*-10.27%
Dec-13.49%-8.91%17.17%-13.52%-0.32%---3.81%
Total-54.81%-37.92%54.55%-51.07%-50.12%-48.92%-31.38%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $1.23
SMA 50: $1.64
SMA 200: $1.60
Current: $0.89
EMA 12: $1.09
EMA 26: $1.29
MACD: -0.2018 | Signal: -0.0090
BEARISH
ADX (14): 42.91
STRONG TREND
+DI: 8.17
−DI: 31.86

Momentum Oscillators

RSI (14): 23.34
OVERSOLD
Stoch %K: 10.04
Stoch %D: 9.86
Williams %R: -99.35

Volume & Volatility

BB Upper: $1.66
BB Lower: $0.80
NEUTRAL
OBV: -57,793,878
Vol SMA 20: 367,969
Vol ROC: -32.77%
ATR: $0.12
True Range: $0.14
HV 20: 92.3%
HV 30: 83.1%
HV 60: 74.7%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-11-20T00:00:00 – 2026-11-18T00:00:00
AI Analysis

Click Frenzy-Pro™ for an AI analysis of this ticker.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

Earnings History
13 of 15 under expected move
Avg Expected Move
22.62%
Avg Actual Move
6.44%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-05-06 After-Close 16.63% 2.20% 0.13x Within
2021-08-05 After-Close 17.39% 5.89% 0.34x Within
2021-11-04 After-Close 15.88% 19.06% 1.20x Exceeded
2022-03-04 After-Close 16.69% 7.96% 0.48x Within
2022-05-06 After-Close 24.10% 7.19% 0.30x Within
2023-03-03 After-Close 20.34% 4.11% 0.20x Within
2023-05-04 After-Close 11.64% 6.61% 0.57x Within
2023-08-08 After-Close 13.12% 8.54% 0.65x Within
2023-11-01 After-Close 15.98% 3.82% 0.24x Within
2024-05-13 After-Close 3.63% 5.75% 1.58x Exceeded
2024-08-02 After-Close 36.41% 6.49% 0.18x Within
2024-11-01 After-Close 47.60% 3.48% 0.07x Within
2025-03-27 After-Close 16.53% 1.48% 0.09x Within
2025-08-07 After-Close 19.71% 8.24% 0.42x Within
2025-10-30 After-Close 63.58% 5.78% 0.09x Within

Earnings calendar: this week’s reports with expected vs actual moves →

INMB Options Activity & IV Rank

INMB IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 395.8%
7-DTE IV: —
Expected Move: $0.55
7-DTE Move: $0.75
Days to Exp: 29 (2026-12-18)

Options Flow · All expiries

Call Volume: 229
Put Volume: 100
P/C Volume: 0.437
BULLISH
Call OI: 4,078
Put OI: 196
P/C OI: 0.048
Total OI: 4,274

ATM Options Pricing

ATM Call: $0.30
ATM Put: $0.25
Call %: 33.6%
Put %: 28.0%

Chain Summary

Chain Volume: 329
Chain OI: 4,274
Last Updated: 11/19/2026

INMB Implied Volatility

30-day IV
395.8%
Nov 19
IV rank
50Medium
Within its 90-session range

Loading implied volatility…

The 30-day IV is the at-the-money implied volatility of options 30 days out, the blue line. The band is its 20-session average, 2 standard deviations either side. Realized volatility is how much INMB actually moved over the last 20 sessions, from closing prices, on the same yearly scale. Without earnings takes each earnings report out of the 30-day IV, sized from what options paid for past reports, so it shows whether options are expensive or cheap apart from the report. Click a name above the chart to show or hide it.

Spread Scanner

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Dealer Positioning
TYPICAL γ

Estimated net dealer gamma is at the 55th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
55%
vs own history
GEX tilt
+0.73
OI-weighted, today
Vanna tilt
+0.64
δ-sensitivity to IV
Charm tilt
-0.97
δ-decay vs time
Vanna tilt +0.64: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.97: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 4 ATM contracts, 1k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Put vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Call vs ATM
IV(call wing) − IV(ATM), in vol points

The same measure on the upside: how the OTM call is priced against the at-the-money strike.

  • Negative (typical) — calls trade below ATM for most stocks and indices, so the sign alone says little.
  • Percentile vs own history: high = upside calls unusually rich for this name (squeezes, takeover talk, commodity supply scares); low = calls cheaper than usual.
Reading them together

Put or call vs ATM tells you how expensive that tail is. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d put —
— pts EXTREME
No data
30 DTE / 10d put —
— pts EXTREME
ATM 196.7% / Put —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)
IV Rank (30 DTE)49.6MediumNov 19

Embed INMB IV rank

INMB's 30-day IV rank (90 sessions) with its 52-week rank, at-the-money IV and a 90-session trend. Updates after each close. Paste the code into any web page or blog post. Email newsletters drop iframes, so link to the page there.

Theme
Preview
Straddle Price (30 DTE)$0.55Nov 19
Beta Analysis

Risk Metrics

Beta: 2.5426
Alpha: -48.67%
Correlation: 0.4613
R-Squared: 21.3%
Stock Volatility: 75.8%
Market Volatility: 13.8%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own INMB
5 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Renaissance Technologies Hedge fund
Jim Simons
$581K
0.00%
#2565 of 3151+903.4%13F
Millennium Management Hedge fund
Izzy Englander
$260K
0.00%
#3401 of 3716new13F
Citadel Hedge fund
Ken Griffin
$173K
0.00%
#5562 of 6285new13F
Point72 Hedge fund
Steve Cohen
$27K
0.00%
#1905 of 1945new13F
Rockefeller Capital Management Family office
Rockefeller family
$5K
0.00%
#4392 of 48580.0%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

INMB Institutional Ownership (13F)

Filings for 2026-09-30
Diluted shares outstanding: 26,940,489 (as of 2026-09-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

66 filers5,061,054 shares$9.34M value18.79% of float
# Filer Shares Value % of Total % of Float Period
1 Vanguard Capital Management LLC 706,424 $1.38M 14.76% 2.62% 2026-09-30
2 AQR Capital Management, LLC Custodian 662,218 $1.08M 11.56% 2.46% 2026-06-30
3 Morgan Stanley Custodian 466,191 $909.07K 9.74% 1.73% 2026-09-30
4 BlackRock, Inc. Custodian 326,857 $637.37K 6.83% 1.21% 2026-09-30
5 RENAISSANCE TECHNOLOGIES LLC 298,000 $581.10K 6.22% 1.11% 2026-09-30
6 Geode Capital Management, LLC Custodian 240,925 $470.08K 5.04% 0.89% 2026-09-30
7 Jane Street Group, LLC Custodian 163,858 $319.52K 3.42% 0.61% 2026-09-30
8 Goldman Sachs Group Inc Custodian 185,245 $301.95K 3.23% 0.69% 2026-06-30
9 Raymond James Financial, Inc. Custodian 147,478 $287.58K 3.08% 0.55% 2026-09-30
10 Vanguard Fiduciary Trust Co 146,380 $285.44K 3.06% 0.54% 2026-09-30
11 Millennium Management LLC Custodian 159,559 $260.08K 2.79% 0.59% 2026-06-30
12 Susquehanna International Group, LLP Custodian 158,452 $258.28K 2.77% 0.59% 2026-06-30
13 State Street Corp 130,763 $254.99K 2.73% 0.49% 2026-09-30
14 UBS Group AG Custodian 110,909 $216.27K 2.32% 0.41% 2026-09-30
15 Westside Investment Management, Inc. 108,300 $211.19K 2.26% 0.40% 2026-09-30
16 Marshall Wace, LLP Custodian 90,357 $176.20K 1.89% 0.34% 2026-09-30
17 Citadel Advisors LLC Custodian 106,231 $173.16K 1.85% 0.39% 2026-06-30
18 ACADIAN ASSET MANAGEMENT LLC 71,164 $137.00K 1.47% 0.26% 2026-09-30
19 GSA CAPITAL PARTNERS LLP 81,991 $134.00K 1.44% 0.30% 2026-06-30
20 Virtu Financial LLC 75,212 $123.00K 1.32% 0.28% 2026-06-30
21 Laird Norton Wetherby Trust Company, LLC 52,000 $84.76K 0.91% 0.19% 2026-06-30
22 PNC Financial Services Group, Inc. Custodian 42,362 $82.61K 0.88% 0.16% 2026-09-30
23 AXQ CAPITAL, LP 41,909 $81.72K 0.88% 0.16% 2026-09-30
24 Focus Advisor Solutions, LLC 41,682 $81.28K 0.87% 0.15% 2026-09-30
25 JPMorgan Chase & Co Custodian 32,522 $63.74K 0.68% 0.12% 2026-09-30
4 filers$181.24K notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $86.39K 47.66% 2026-06-30
2 GROUP ONE TRADING LLC Custodian $46.99K 25.93% 2026-09-30
3 Citadel Advisors LLC Custodian $27.38K 15.11% 2026-06-30
4 Simplex Trading, LLC Custodian $20.48K 11.30% 2026-09-30
3 filers$59.62K notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $46.94K 78.74% 2026-06-30
2 GROUP ONE TRADING LLC Custodian $9.75K 16.35% 2026-09-30
3 Simplex Trading, LLC Custodian $2.92K 4.91% 2026-09-30

INMB Insider Trading (Form 4)

Latest: 2026-09-23
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-09-23 Ronnie Duane Clark Director Grant (A) +100,000 opt — EDGAR
2026-09-17 James Sapirstein Director Grant (A) +100,000 opt — EDGAR
2026-07-07 David J Moss Chief Executive Officer Exer (M) +9,014 $1.40 $12.6K EDGAR
2026-07-07 Scott Juda Director Exer (M) +14,801 $1.40 $20.7K EDGAR
2026-07-07 Mark William Lowdell Chief Scientific Officer Exer (M) +7,211 $1.40 $10.1K EDGAR
2025-12-02 Scott Juda Director Grant (A) +150,000 opt — EDGAR
2025-12-02 Mark William Lowdell Chief Scientific Officer Grant (A) +600,000 opt — EDGAR
2025-12-02 Marcia Allen Director Grant (A) +150,000 opt — EDGAR
2025-12-02 Cory Randall Ellspermann CFO Grant (A) +300,000 opt — EDGAR
2025-12-02 James Kelly Ganjei Director Grant (A) +150,000 opt — EDGAR
2025-12-02 Timothy j Schroeder Director Grant (A) +150,000 opt — EDGAR
2025-12-02 David J Moss Chief Executive Officer Grant (A) +750,000 opt — EDGAR
2025-11-18 Mark William Lowdell Chief Scientific Officer Mixed — — EDGAR
2025-11-18 Timothy j Schroeder Director Mixed — — EDGAR
2025-11-18 James Kelly Ganjei Director Mixed — — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

INMB Insider Holdings

6 insiders · @ $0.91
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Raymond Joseph Tesi President and CEO 1,554,106 $1.41M -$573.6K 23 2024-12-09
2 Mark William Lowdell Chief Scientific Officer 1,518,017 $1.38M -$535.7K 14 2026-07-07
3 David J Moss Chief Executive Officer 1,294,883 $1.18M -$74.6K 25 2026-07-07
4 Scott Juda Director 158,007 $143.8K $455.2K 17 2026-07-07
5 Timothy j Schroeder Director 82,187 $74.8K -$1.69M 15 2025-12-02
6 James Kelly Ganjei Director 17,793 $16.2K $0 9 2025-12-02
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

INMB Board & Officers

As of SEC filings through Sep 23, 2026

Directors 8

Officers 3

Changes in the last 10 years (24)
Sep 8, 2026Ronnie Duane Clark became a director
Sep 8, 2026James Sapirstein became a director
Nov 18, 2025Mark William Lowdell no longer listed as a 10% owner in SEC filings
Nov 18, 2025David J Moss no longer listed as a 10% owner in SEC filings
Nov 18, 2025David J Moss listed as Chief Executive Officer (previously Chief Financial Officer) in SEC filings
Nov 18, 2025David J Moss first listed as a director in an SEC filing
Aug 4, 2025Cory Randall Ellspermann became Interim CFO
Jul 5, 2024The company announced the departure of Edgardo Baracchini Jr from the board in an SEC filing
May 16, 2024David J Moss listed as Chief Financial Officer (previously CFO, Treasurer & Secretary) in SEC filings
Nov 19, 2019Marcia Allen became a director
Aug 6, 2019Edgardo Baracchini Jr became a director
May 1, 2019Linda F Powers became a 10% owner
Feb 1, 2019Xencor Inc became a 10% owner
Feb 1, 2019Timothy j Schroeder became a director
Feb 1, 2019Scott Juda became a director
Feb 1, 2019Raymond Joseph Tesi became a director
Feb 1, 2019Raymond Joseph Tesi became a 10% owner
Feb 1, 2019Raymond Joseph Tesi became President and CEO
Feb 1, 2019Mark William Lowdell became a 10% owner
Feb 1, 2019Mark William Lowdell became Chief Scientific Officer
Not reported recently (3)
  • Xencor Inc · Last reported as a 10% owner in an SEC filing dated Sep 8, 2021
  • Linda F Powers · Last reported as a 10% owner in an SEC filing dated Jan 29, 2020
  • David Edmund Szymkowski · Last reported as a director in an SEC filing dated Feb 8, 2019
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

INMB Proposed Insider Sales (Form 144)

Latest: 2023-07-12
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2023-07-12 CTI Holdings, Inc Director 60,000 $960.1K 2023-07-12 THE CHARLES SCHWAB CORPORATION 10b5-1 EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-05
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Event Link
2026-10-29 Material agreement · Unregistered share sale · Regulation FD disclosure EDGAR
2026-10-21 Regulation FD disclosure · Other events EDGAR
2026-09-14 Director or officer change · Other events EDGAR
2026-07-31 Other events EDGAR
2026-07-01 Material agreement EDGAR
2026-06-23 Other events EDGAR
2026-06-17 Director or officer change · Shareholder vote results EDGAR
2026-06-02 Other events EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-11-05 0001213900-26-116359 EDGAR
2026-08-06 0001213900-26-086135 EDGAR
ETF Holders
5 ETFs hold INMB
5 shown · $925.68K total exposure · 0.01% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $560,205 — 2026-10-31
2 VXF Vanguard Extended Market ETF Vanguard 0.00% $284,193 — 2026-10-31
3 IWC iShares Micro-Cap ETF iShares (BlackRock) 0.01% $71,625 $1.2B 2026-11-17
4 DFMC Dimensional US Micro Cap ETF Dimensional 0.00% $5,557 — 2026-11-17
5 DFAS Dimensional US Small Cap ETF Dimensional 0.00% $4,096 — 2026-11-17
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-0.62
TTM Revenue
$0.00
TTM Net Income
$-16.95M
TTM Op. Cash Flow
$-12.91M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q3 '262026-09-30$0.00$-5.01M$-0.17$-3.39M
Q2 '262026-06-30$0.00$-1.27M$-0.05$-3.17M
Q1 '262026-03-31$0.00$-5.41M$-0.20$-3.40M
Q4 '252025-12-31$0.00$-5.26M$-0.20$-2.94M
Q3 '252025-09-30$0.00$-7.43M$-0.24$-5.44M
Q2 '252025-06-30—$-24.46M$-1.05$-7.38M
Q1 '252025-03-31$50.00K$-9.74M$-0.43$-6.82M
Q4 '242024-12-31$0.00$-9.22M$-0.40$-11.01M
Q3 '242024-09-30—$-12.09M$-0.60$-6.99M
Q2 '242024-06-30—$-9.75M$-0.50$-7.89M
Q1 '242024-03-31$14.00K$-11.03M$-0.61$-7.48M
Q4 '232023-12-31$28.00K$-8.41M$-0.47$-3.40M
Q3 2026 • period ending 2026-09-30 • filed 2026-11-05
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
1.36
P/S
—
EV/EBITDA
—
EV/Sales
—
ROE
-93.8%
ROA
-78.8%
Div Yield
0.00%
FCF Yield
-52.67%
Debt/Equity
0.00
Current Ratio
—
Market Cap
$24.52M
as of 2026-11-19

INMB vs Peers

Related companies, largest first
Company Market cap P/E Revenue growth YTD IV rank
AMGN Amgen Inc $240.1B 25.4 +8.2% +33.5% 46
GILD Gilead Sciences Inc $209.6B — +6.5% +36.1% 62
MRNA Moderna, Inc. Common Stock $79.6B — +13.1% +539.9% 32
ARGX argenx SE American Depositary Shares $59.2B — — +11.7% 90
BIIB Biogen Inc. Common Stock $37.2B 104.9 +2.3% +38.0% 100
RVMD Revolution Medicines, Inc. Common Stock $34.6B — — +106.0% 72
BNTX BioNTech SE American Depositary Share $20.6B — — −14.8% 36
EXEL Exelixis Inc $16.7B 19.6 +9.1% +50.4% 30
INMB INmune Bio Inc. Common stock $32M — — −40.9% 49
Peer median $48.2B 25.4 +8.2% +37.1% 54

P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.

Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
2.66M
SI % of Float
10.78%
Days to Cover
14.40
Short Vol Ratio
72.1%
Free Float
24.65M
Float %
88.8%
Short interest 2026-10-30 • Short volume 2026-11-18 • Float 2026-08-14